Get the Stockscreener App
2.16
1.59%
-0.035
Kiora Pharmaceuticals Inc stock is traded at $2.16, with a volume of 48,909.
It is down -1.59% in the last 24 hours and down -21.17% over the past month.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
See More
Previous Close:
$2.195
Open:
$2.204
24h Volume:
48,909
Relative Volume:
1.06
Market Cap:
$7.42M
Revenue:
-
Net Income/Loss:
$2.81M
P/E Ratio:
-0.1505
EPS:
-14.3497
Net Cash Flow:
$7.14M
1W Performance:
-7.30%
1M Performance:
-21.17%
6M Performance:
-30.02%
1Y Performance:
-36.41%
1-Day Range:
$2.16
$2.23
1-Week Range:
$2.16
$2.3899
52-Week Range:
$2.16
$4.18
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Name
Kiora Pharmaceuticals Inc
Sector
Industry
Phone
858-224-9600
Address
169 SAXONY RD., ENCINITAS
Compare KPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
2.16 | 8.07M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Kiora Pharmaceuticals Inc Stock (KPRX) Latest News
Can Kiora Pharmaceuticals Inc. stock sustain free cash flow growthJuly 2025 Intraday Action & Community Trade Idea Sharing - newser.com
Can Kiora Pharmaceuticals Inc. stock resist market sell offsIPO Watch & Expert Curated Trade Ideas - newser.com
News impact scoring models applied to Kiora Pharmaceuticals Inc.2025 Trading Volume Trends & Comprehensive Market Scan Insights - newser.com
Will Kiora Pharmaceuticals Inc. (7EY) stock beat Nasdaq index returnsJuly 2025 Decliners & Advanced Technical Analysis Signals - newser.com
Intraday pattern recognizer results for Kiora Pharmaceuticals Inc.Trade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
What candlestick patterns are forming on Kiora Pharmaceuticals Inc.Earnings Growth Report & Low Drawdown Investment Ideas - newser.com
Is Kiora Pharmaceuticals Inc. stock supported by strong cash flows2025 Market Outlook & AI Forecast Swing Trade Picks - newser.com
How moving averages guide Kiora Pharmaceuticals Inc. trading2025 Market Trends & Low Drawdown Investment Ideas - newser.com
Heatmap analysis for Kiora Pharmaceuticals Inc. and competitorsWeekly Trade Analysis & Accurate Buy Signal Alerts - newser.com
Published on: 2025-11-14 09:18:33 - Fundação Cultural do Pará
How to track smart money flows in Kiora Pharmaceuticals Inc.2025 EndofYear Setup & Technical Confirmation Alerts - newser.com
Will Kiora Pharmaceuticals Inc. stock benefit from infrastructure spendingJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Published on: 2025-11-12 16:48:17 - newser.com
Real time breakdown of Kiora Pharmaceuticals Inc. stock performanceTrend Reversal & Reliable Entry Point Trade Alerts - newser.com
Chart based exit strategy for Kiora Pharmaceuticals Inc.2025 Market Sentiment & Weekly High Return Opportunities - newser.com
Published on: 2025-11-11 05:52:17 - newser.com
Kiora Pharmaceuticals Reports Improved Financial Performance - TipRanks
Will Kiora Pharmaceuticals Inc. (7EY) stock benefit from commodity supercycle2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
Can Kiora Pharmaceuticals Inc. (7EY) stock attract ESG investmentsJuly 2025 Sentiment & Fast Gain Swing Alerts - newser.com
Analyzing recovery setups for Kiora Pharmaceuticals Inc. investorsMarket Trend Review & Risk Adjusted Buy and Sell Alerts - newser.com
KPRXKIORA PHARMACEUTICALS INC Latest Stock News & Market Updates - Stock Titan
Published on: 2025-11-07 09:17:23 - newser.com
Kiora Pharmaceuticals reports Q3 results, advances retinal disease trials By Investing.com - Investing.com Nigeria
Kiora Pharmaceuticals reports Q3 results, advances retinal disease trials - Investing.com India
Kiora Pharmaceuticals Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Kiora Pharmaceuticals Inc Stock (KPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):